These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 10211850)
21. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. O'Keane V; Dinan TG Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948 [TBL] [Abstract][Full Text] [Related]
22. Stress hormone dysregulation at rest and after serotonergic stimulation among alcohol-dependent men with extended abstinence and controls. Anthenelli RM; Maxwell RA; Geracioti TD; Hauger R Alcohol Clin Exp Res; 2001 May; 25(5):692-703. PubMed ID: 11411461 [TBL] [Abstract][Full Text] [Related]
23. Serotonergic modulation of dopamine measured with [11C]raclopride and PET in normal human subjects. Smith GS; Dewey SL; Brodie JD; Logan J; Vitkun SA; Simkowitz P; Schloesser R; Alexoff DA; Hurley A; Cooper T; Volkow ND Am J Psychiatry; 1997 Apr; 154(4):490-6. PubMed ID: 9090335 [TBL] [Abstract][Full Text] [Related]
24. d-fenfluramine-induced prolactin responses in mania: evidence for serotonergic subsensitivity. Thakore JH; O'Keane V; Dinan TG Am J Psychiatry; 1996 Nov; 153(11):1460-3. PubMed ID: 8890681 [TBL] [Abstract][Full Text] [Related]
26. The neuroendocrine response to d-fenfluramine in women with premenstrual depression. Bancroft J; Cook A J Affect Disord; 1995 Dec; 36(1-2):57-64. PubMed ID: 8988266 [TBL] [Abstract][Full Text] [Related]
27. Oral d-fenfluramine test in treatment-refractory depression. Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group. Prochazka H; Sjögren M; Agren H J Affect Disord; 2000; 57(1-3):201-8. PubMed ID: 10708832 [TBL] [Abstract][Full Text] [Related]
28. Plasma oxytocin in response to pharmaco-challenge to D-fenfluramine and placebo in healthy men. Lee R; Garcia F; van de Kar LD; Hauger RD; Coccaro EF Psychiatry Res; 2003 May; 118(2):129-36. PubMed ID: 12798977 [TBL] [Abstract][Full Text] [Related]
29. Hormone responses to fenfluramine and placebo challenge in endogenous depression. Lichtenberg P; Shapira B; Gillon D; Kindler S; Cooper TB; Newman ME; Lerer B Psychiatry Res; 1992 Aug; 43(2):137-46. PubMed ID: 1410069 [TBL] [Abstract][Full Text] [Related]
30. Lack of effect of HPA axis hyperactivity on hormonal responses to d-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour. Duval F; Mokrani MC; Correa H; Bailey P; Valdebenito M; Monreal J; Crocq MA; Macher JP Psychoneuroendocrinology; 2001 Jul; 26(5):521-37. PubMed ID: 11337135 [TBL] [Abstract][Full Text] [Related]
31. Cigarette smoking decreases the prolactin response to serotonergic stimulation in subgroups of alcoholics and controls. Anthenelli RM; Maxwell RA Alcohol Clin Exp Res; 2000 Jul; 24(7):987-95. PubMed ID: 10924001 [TBL] [Abstract][Full Text] [Related]
32. Risperidone is associated with blunting of D-fenfluramine evoked serotonergic responses in schizophrenia. Jones H; Curtis VA; Wright PA; Lucey JV Int Clin Psychopharmacol; 1998 Sep; 13(5):199-203. PubMed ID: 9817624 [TBL] [Abstract][Full Text] [Related]
33. Prolactin response to D-fenfluramine challenge test as a predictor of treatment response to haloperidol in acute schizophrenia. Mohr P; Horácek J; Motlová L; Libiger J; Czobor P Schizophr Res; 1998 Feb; 30(1):91-9. PubMed ID: 9542792 [TBL] [Abstract][Full Text] [Related]
34. Serotonin function in detoxified heroin abusers: prolactin and cortisol responses to fenfluramine challenge. Gerra G; Fertonani G; Tagliavini P; Zaimovic A; Delsignore R; Maestri D; Avanzini P; Caccavari R; Brambilla F Psychiatry Res; 1995 Sep; 58(2):153-60. PubMed ID: 8570767 [TBL] [Abstract][Full Text] [Related]
36. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. Siever LJ; Murphy DL; Slater S; de la Vega E; Lipper S Life Sci; 1984 Mar; 34(11):1029-39. PubMed ID: 6700367 [TBL] [Abstract][Full Text] [Related]
37. Differences between morning and afternoon hormonal responses to D-fenfluramine in healthy humans. Monteleone P; Bortolotti F; Orazzo C; Serino I; Maj M Psychoneuroendocrinology; 1997 Feb; 22(2):79-87. PubMed ID: 9149330 [TBL] [Abstract][Full Text] [Related]
38. Abnormal serotonergic control of prolactin and cortisol secretion in patients with seasonal affective disorder. Coiro V; Volpi R; Marchesi C; De Ferri A; Davoli C; Caffarra P; Rossi G; Caffarri G; Davolio M; Chiodera P Psychoneuroendocrinology; 1993; 18(8):551-6. PubMed ID: 8127946 [TBL] [Abstract][Full Text] [Related]
39. Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response. Cleare AJ; Murray RM; O'Keane V Biol Psychiatry; 1998 Oct; 44(7):555-61. PubMed ID: 9787879 [TBL] [Abstract][Full Text] [Related]
40. 5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects. Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R Psychopharmacology (Berl); 1996 Sep; 127(2):108-12. PubMed ID: 8888375 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]